PATENT CLAIM ANALYSIS

Application Number: 15890284
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.

Claim (Index 128):
The method of  claim 122 , wherein each of the multiple doses is 30 IU/kg.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 88.0
- Lexical Diversity: 2.13636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14982934', '15043457', '13809276', '15043445', '15043455']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8854066270635886
- 35 USC 102 Novelty (BERT): 0.6967100780076564
- Combined Prediction Score: 0.8665369721579954
- Mean Citation Score: 870.180564
- Max Citation Score: 879.1177
- Similarity Product: 669.0687570212482

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test